Exploiting an Asp-Glu “switch” in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia

Wagner F, Benajiba L, Campbell A, We{\"ıwer M, Sacher J, Gale J, Ross L, Puissant A, Alexe G, Conway A, et al. Exploiting an Asp-Glu “switch” in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia. Science translational medicine. 2018;10(431).